Industry payments to Connecticut providers
Source: CMS Open Payments 2025 general payments by recipient state, company-reported. Payments do not imply wrongdoing and are separate from Medicare billing.
The top 40 companies paid $28,200,315 to Connecticut recipients in 2025.
Consulting: $11,974,963Speaker / faculty: $10,561,536Food & beverage: $5,916,855Debt forgiveness: $4,258,204Travel & lodging: $3,189,473Royalty / license: $1,837,294Space rental or facility fees (teachin…: $1,330,638Acquisitions: $1,226,137
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28,728 | $2,620,356 |
| Siemens Medical Solutions USA, Inc. | 61 | $1,693,855 |
| Medtronic, Inc. | 3,721 | $1,632,393 |
| Lilly USA, LLC | 5,761 | $1,150,092 |
| GENZYME CORPORATION | 2,694 | $1,116,326 |
| Alcon Vision LLC | 1,205 | $1,076,282 |
| Mozarc Medical US LLC | 5 | $1,043,961 |
| PFIZER INC. | 7,623 | $1,006,226 |
| Stryker Corporation | 1,804 | $956,581 |
| INTUITIVE SURGICAL, INC. | 814 | $893,881 |
| Eli Lilly and Company | 249 | $875,903 |
| Arthrex, Inc. | 535 | $788,565 |
| AstraZeneca Pharmaceuticals LP | 7,166 | $785,331 |
| Amgen Inc. | 5,106 | $776,766 |
| Abbott Laboratories | 2,678 | $711,286 |
| Janssen Biotech, Inc. | 6,402 | $696,628 |
| Davol Inc. | 110 | $649,099 |
| Alkermes, Inc. | 1,308 | $635,042 |
| UCB, Inc. | 3,101 | $630,705 |
| Regeneron Healthcare Solutions, Inc. | 2,472 | $617,998 |
| Novo Nordisk Inc | 5,242 | $574,390 |
| Boston Scientific Corporation | 2,584 | $557,862 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3,841 | $533,871 |
| Smith+Nephew, Inc. | 1,081 | $484,144 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 149 | $461,749 |
| E.R. Squibb & Sons, L.L.C. | 4,303 | $458,847 |
| Axsome Therapeutics, Inc. | 2,159 | $446,621 |
| Edwards Lifesciences Corporation | 801 | $445,105 |
| Gilead Sciences, Inc. | 2,336 | $391,990 |
| Merck Sharp & Dohme LLC | 2,429 | $376,739 |
| Incyte Corporation | 1,888 | $360,161 |
| Alnylam Pharmaceuticals Inc. | 466 | $355,798 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2,514 | $345,410 |
| VERTEX PHARMACEUTICALS INCORPORATED | 420 | $311,950 |
| Neurocrine BioSciences, Inc. | 2,063 | $303,995 |
| Sumitomo Pharma America, Inc. | 1,184 | $293,900 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3,871 | $290,232 |
| Medical Device Business Services, Inc. | 398 | $285,187 |
| Galderma Laboratories, L.P. | 1,507 | $282,828 |
| GlaxoSmithKline, LLC. | 6,982 | $282,261 |
"Who does it pay?" opens the List Builder: free count and top 3 recipients, full list with addresses and phone for $29 or included with membership.
